{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:50:37Z","timestamp":1785883837807,"version":"3.56.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.beha.2005.02.003","type":"journal-article","created":{"date-parts":[[2005,7,17]],"date-time":"2005-07-17T12:33:11Z","timestamp":1121603591000},"page":"537-552","source":"Crossref","is-referenced-by-count":22,"title":["Gene expression profiling and multiple myeloma"],"prefix":"10.1016","volume":"18","author":[{"given":"John","family":"Shaughnessy Jr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghuang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barthel","family":"Barlogie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2005.02.003_bib1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1034\/j.1600-065X.2003.00052.x","article-title":"Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma","volume":"194","author":"Bergsagel","year":"2003","journal-title":"Immunol Rev"},{"key":"10.1016\/j.beha.2005.02.003_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V91.1.3","article-title":"Multiple myeloma: increasing evidence for a multistep transformation process","volume":"91","author":"Hallek","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.02.003_bib3","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1038\/sj.onc.1204641","article-title":"Chromosome translocations in multiple myeloma","volume":"20","author":"Bergsagel","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.beha.2005.02.003_bib4","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1182\/blood.V99.5.1745","article-title":"Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells","volume":"99","author":"Zhan","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.02.003_bib5","unstructured":"J. Hardin, M. Waddell, Z. Cheng. 2004. Toward the development of diagnostic models capable of distinguishing multiple myeloma, MGUS, and normal plasma cells using global gene expression profiles. Stat Appl Genet Mol Biol; 3(1): Article 10.http:\/\/www.bepress.com\/sagmb\/vol3\/iss1\/art10."},{"key":"10.1016\/j.beha.2005.02.003_bib6","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.02.003_bib7","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1182\/blood-2002-06-1737","article-title":"Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development","volume":"101","author":"Zhan","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.02.003_bib8","first-page":"1227","article-title":"Gene Expression profiling of CD19 and CD138-enriched cells from Waldenstrom's macroglobulinemia (WM) reveals distinct classes and novel WM-specific genes","volume":"100","author":"Shaughnessy","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.02.003_bib9","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood.V100.4.1113.h81602001113_1113_1122","article-title":"Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts","volume":"100","author":"Tarte","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.02.003_bib10","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2002-10-3161","article-title":"Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation","author":"Tarte","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.02.003_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrc746","article-title":"Multiple myeloma: evolving genetic events and host interactions","volume":"2","author":"Kuehl","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.beha.2005.02.003_bib12","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1158\/0008-5472.CAN-03-2876","article-title":"Genetics and cytogenetics of multiple myeloma: a workshop report","volume":"64","author":"Fonseca","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2005.02.003_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1182\/blood.V98.1.217","article-title":"Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma","volume":"98","author":"Shaughnessy","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.02.003_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0037-1963(01)90022-8","article-title":"Developmental therapeutics for multiple myeloma\u2013a road map for the future","volume":"38","author":"Shaughnessy","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.beha.2005.02.003_bib15","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1182\/blood-2002-09-2801","article-title":"A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH\/MMSET fusion transcript","volume":"101","author":"Santra","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.02.003_bib16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s002770100296","article-title":"Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma","volume":"80","author":"Worel","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1016\/j.beha.2005.02.003_bib17","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1182\/blood-2002-09-2873","article-title":"Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with total therapy I: interpretation in the context of global gene expression","volume":"101","author":"Shaughnessy","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.02.003_bib18","first-page":"715","article-title":"Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study","volume":"62","author":"Fonseca","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2005.02.003_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1365-2141.2003.03948.x","article-title":"Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II","volume":"120","author":"Shaughnessy","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.02.003_bib20","first-page":"1553","article-title":"Global GEP can be used to accurately predict chromosome 13 deletion in MM","volume":"98","author":"Zhan","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.02.003_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","article-title":"Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"1","author":"Yeoh","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beha.2005.02.003_bib22","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood-2003-01-0338","article-title":"Classification of pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"102","author":"Ross","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.02.003_bib23","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMoa031046","article-title":"Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia","volume":"350","author":"Bullinger","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.02.003_bib24","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa040465","article-title":"Prognostically useful gene-expression profiles in acute myeloid leukemia","volume":"350","author":"Valk","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.02.003_bib25","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa032520","article-title":"Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes","volume":"350","author":"Lossos","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.02.003_bib26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nm0102-68","article-title":"Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning","volume":"8","author":"Shipp","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.beha.2005.02.003_bib27","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.02.003_bib28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1182\/asheducation-2003.1.248","article-title":"Advances in biology and therapy of multiple myeloma","author":"Barille-Nion","year":"2003","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.1016\/j.beha.2005.02.003_bib29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/blood-2004-01-0037","article-title":"Advances in biology of multiple myeloma: clinical applications","volume":"104","author":"Hideshima","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.02.003_bib30","series-title":"The Analysis of Binary Data","author":"Cox","year":"1989"},{"key":"10.1016\/j.beha.2005.02.003_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/1521-1878(200101)23:1<77::AID-BIES1010>3.3.CO;2-5","article-title":"The Ran-GTPase and cell-cycle control","volume":"23","author":"Moore","year":"2001","journal-title":"Bioessays"},{"key":"10.1016\/j.beha.2005.02.003_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0092-8674(01)00218-5","article-title":"Running on Ran: nuclear transport and the mitotic spindle","volume":"104","author":"Dasso","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.beha.2005.02.003_bib33","doi-asserted-by":"crossref","first-page":"R502","DOI":"10.1016\/S0960-9822(02)00970-3","article-title":"The Ran GTPase: theme and variations","volume":"12","author":"Dasso","year":"2002","journal-title":"Curr Biol"},{"key":"10.1016\/j.beha.2005.02.003_bib34","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1042\/bj20030171","article-title":"Zinc-fingers and homeoboxes (ZHX) 2, a novel member of the ZHX family, functions as a transcriptional repressor","volume":"373","author":"Kawata","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.beha.2005.02.003_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/geno.1998.5498","article-title":"cDNA cloning, gene characterization and 13q14.3 chromosomal assignment of CHC1-L, a chromosome condensation regulator-like guanine nucleotide exchange factor","volume":"54","author":"Devilder","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.beha.2005.02.003_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood-2003-04-1045","article-title":"Treatment of multiple myeloma","volume":"103","author":"Barlogie","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.02.003_bib37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1034\/j.1600-065X.2003.00054.x","article-title":"Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profiling","volume":"194","author":"Shaughnessy","year":"2003","journal-title":"Immunol Rev"},{"key":"10.1016\/j.beha.2005.02.003_bib38","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"Tian","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.02.003_bib39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1034\/j.1600-065X.2003.00053.x","article-title":"Novel therapeutic approaches for multiple myeloma","volume":"194","author":"Hideshima","year":"2003","journal-title":"Immunol Rev"},{"key":"10.1016\/j.beha.2005.02.003_bib40","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1182\/blood-2002-10-3146","article-title":"Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays","volume":"101","author":"Chauhan","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.02.003_bib41","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/sj.onc.1205205","article-title":"Identification of genes regulated by dexamethasone in multiple myeloma cells using oligonucleotide arrays","volume":"21","author":"Chauhan","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.beha.2005.02.003_bib42","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1073\/pnas.2536759100","article-title":"Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications","volume":"101","author":"Mitsiades","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beha.2005.02.003_bib43","first-page":"67","article-title":"Insights from the gene expression profiling of multiple myeloma","volume":"3","author":"Claudio","year":"2004","journal-title":"Curr Hematol Rep"},{"key":"10.1016\/j.beha.2005.02.003_bib44","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1182\/blood-2002-01-0008","article-title":"A molecular compendium of genes expressed in multiple myeloma","volume":"100","author":"Claudio","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.02.003_bib45","doi-asserted-by":"crossref","first-page":"10399","DOI":"10.1073\/pnas.1630810100","article-title":"Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile","volume":"100","author":"Jenner","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beha.2005.02.003_bib46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ni907","article-title":"Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1","volume":"4","author":"Iwakoshi","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.beha.2005.02.003_bib47","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1101\/gad.13.10.1211","article-title":"Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls","volume":"13","author":"Kaufman","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.beha.2005.02.003_bib48","doi-asserted-by":"crossref","first-page":"49047","DOI":"10.1074\/jbc.M205011200","article-title":"Activation of an unfolded protein response during differentiation of antibody-secreting B cells","volume":"277","author":"Gass","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.beha.2005.02.003_bib49","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1074-7613(03)00024-4","article-title":"Sequential waves of functionally related proteins are expressed when B cells prepare for antibody secretion","volume":"18","author":"van Anken","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.beha.2005.02.003_bib50","doi-asserted-by":"crossref","first-page":"9946","DOI":"10.1073\/pnas.1334037100","article-title":"Proteasome inhibitors disrupt the unfolded protein response in myeloma cells","volume":"100","author":"Lee","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beha.2005.02.003_bib51","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1182\/blood-2002-08-2543","article-title":"Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341","volume":"101","author":"Hideshima","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.02.003_bib52","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1182\/blood-2002-06-1768","article-title":"The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications","volume":"101","author":"Mitsiades","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.02.003_bib53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3816\/CLM.2003.n.022","article-title":"A prospective, open-label safety and efficacy study of combination treatment with bortezomib (PS-341), velcade and melphalan in patients with relapsed or refractory multiple myeloma","volume":"4","author":"Yang","year":"2003","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.beha.2005.02.003_bib54","first-page":"122a","article-title":"Phase I study of the proteosome inhibitor Bortezomib (PS-341), Velcade) in combination with pegylated liposomal doxurobicin (Doxil) in patiens with refractory hematologic malignancies","volume":"100","author":"Orlowski","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.02.003_bib55","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","article-title":"LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development","volume":"107","author":"Gong","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.beha.2005.02.003_bib56","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature01593","article-title":"A role for Wnt signalling in self-renewal of haematopoietic stem cells","volume":"423","author":"Reya","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.beha.2005.02.003_bib57","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature01611","article-title":"Wnt proteins are lipid-modified and can act as stem cell growth factors","volume":"423","author":"Willert","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.beha.2005.02.003_bib58","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1535-6108(04)00019-4","article-title":"Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma","volume":"5","author":"Hurt","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beha.2005.02.003_bib59","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1182\/blood.V91.12.4457","article-title":"Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma","volume":"91","author":"Chesi","year":"1998","journal-title":"Blood"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692605000538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692605000538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T07:53:34Z","timestamp":1586332414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692605000538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S1521692605000538"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2005.02.003","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}